It took Prosper AI just six months to more than double its customer count. The New York-based company, which builds voice agents for healthcare providers, now says it has raised $30 million to keep up with demand. The funding round was led by Andreessen Horowitz.
Y Combinator, Base10, Emergence Capital, and Company Ventures also participated. The money arrives as Prosper AI reports it has added more than 40 healthcare providers to its client list in the last half-year.
That surge in sales is the real story here. The company’s platform lets a hospital or clinic build a patient-facing voice agent in days. You upload a question-answering guide.
The system does the rest. The result is an automated assistant that can handle scheduling, billing questions, and prescription renewal reminders.
Those tasks eat up staff time. A nurse or receptionist who spends twenty minutes on the phone rescheduling appointments is not doing clinical work. Prosper AI’s software aims to take over that burden.
The voice agents collect patient information, find open time slots, and sync requests to backend systems. They can also postpone or cancel appointments when plans change. The platform does not stop at patient calls.
It can notify patients about annual checkups. It can help insurance companies process information requests from providers.
The company has built quality assurance tools into the interface, letting healthcare organizations test the voice agents and verify their accuracy before deployment. That testing layer matters. A voice agent that books the wrong appointment or misses a cancellation creates chaos, not efficiency.
The built-in QA tools give providers a way to catch errors before patients encounter them. The timing of this funding is telling.
Healthcare has been slow to adopt AI for direct patient interaction. Concerns about accuracy, privacy, and patient trust have kept many providers cautious. Prosper AI’s rapid customer growth suggests that caution is fading.
More than 40 organizations have decided the trade-offs are worth it. The company is not alone in this space. Several startups are building similar tools.
But the backing from Andreessen Horowitz and Y Combinator signals that investors see a clear path to scale here. The $30 million will likely go toward expanding the sales team and improving the product.
What is less clear is how patients will react. A voice agent that handles a prescription refill is one thing. A voice agent that handles a cancer screening reminder is another.
The technology works the same way. The emotional weight of the interaction is different.
Prosper AI’s quality assurance tools can test for accuracy. They cannot test for patient comfort. The company’s growth suggests providers believe the benefits outweigh the risks.
Staff burnout is a real problem in healthcare. Automating routine phone work frees up people for higher-value tasks. If the voice agents work as advertised, the math is simple.
But the proof will be in the patient experience. A voice agent that sounds natural and gets the details right will be accepted.
One that frustrates callers will be a liability. Prosper AI’s quality assurance tools are designed to prevent that outcome, but no testing environment perfectly replicates real-world use. For now, the company is betting that its approach is good enough.
The $30 million says investors agree. The next six months will show whether patients do too.
